Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer

This study has been terminated.
(funding terminated)
Sponsor:
Collaborators:
United States Department of Defense
Indiana University School of Medicine
Emory University
Information provided by:
Hoosier Cancer Research Network
ClinicalTrials.gov Identifier:
NCT01232881
First received: November 1, 2010
Last updated: April 27, 2011
Last verified: April 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2010
  Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)